{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:29:23Z","timestamp":1781224163028,"version":"3.54.1"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI2001266, RD16\/0012\/0014"],"award-info":[{"award-number":["PI2001266, RD16\/0012\/0014"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Rheumatoid arthritis (RA) is a common chronic inflammatory disease affecting primarily peripheral joints, which is only partially controlled with current treatments. RA leads to pain, disability, deformities, and life expectancy shortening. Its pathogenesis is complex involving multiple cell types and signaling pathways that we incompletely understand. One of the pathways we have elucidated starts with WNT5A signaling and contributes to the aggressive phenotype of the RA synoviocytes through RYK-RhoA\/ROCK signaling. Now, we have explored the contribution of ROCK to arthritis<jats:italic>in vivo<\/jats:italic>, using the K\/BxN serum-transfer arthritis model; and to osteoclastogenesis, using the arthritis model and cells from patients with inflammatory arthritis. The mice and cells were treated with the ROCK inhibitor Y-27632 that caused a significant improvement of arthritis and reduction of osteoclastogenesis. The improvement in mouse arthritis was observed in the clinical evaluation and, histologically, in synovial inflammation, cartilage damage, bone erosion, and the abundance of multinucleated TRAP+ cells. Expression of inflammatory mediators in the arthritic joints, as assessed by real-time PCR, was also significantly reduced. The effect on bone was confirmed with<jats:italic>in vitro<\/jats:italic>assays using bone marrow precursors of arthritic mice and peripheral blood monocytes of patients with inflammatory arthritis. These assays showed dramatically reduced osteoclastogenesis and bone resorption. Overall, our findings suggest that ROCK inhibition could be part of a therapeutic strategy for RA by its dual action on inflammation and bone erosion.<\/jats:p>","DOI":"10.3389\/fimmu.2022.858069","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T11:33:50Z","timestamp":1660217630000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["ROCK inhibition with Y-27632 reduces joint inflammation and damage in serum-induced arthritis model and decreases in vitro osteoclastogenesis in patients with early arthritis"],"prefix":"10.3389","volume":"13","author":[{"given":"Angela","family":"Rodr\u00edguez-Trillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"P\u00e9rez-Pamp\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Rodr\u00edguez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mera-Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar2666","article-title":"Tretament options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review","author":"Rubbert-Roth","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/ar4594","article-title":"Why is there persistent disease despite biologic therapy? importance of early intervention","volume":"16","author":"Emery","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13075-020-02354-1","article-title":"Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis","volume":"22","author":"Novella-Navarro","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","article-title":"Duality of fibroblast-like synoviocytes in RA: a passive responders and imprinted aggressors","volume":"9","author":"Bottini","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.153","article-title":"Bone erosion in rheumatoid arthritis: Mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4321\/S1889-836X2014000400007","article-title":"Osteoclastos: mucho m\u00e1s que c\u00e9lulas remodeladoras del hueso","volume":"6","author":"Arboleya","year":"2014","journal-title":"Rev Osteoporos y Metab Miner"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2004.12.009","article-title":"The fibroblast-like synovial cell in rheumatoid arthritis: A key player in inflammation and joint destruction","volume":"115","author":"Mor","year":"2005","journal-title":"Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.555245","article-title":"Non-canonical WNT5A signaling through RYK contributes to aggressive phenotype of the rheumatoid fibroblast-like synoviocytes","volume":"11","author":"Rodr\u00edguez-Trillo","year":"2020","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M509433200","article-title":"RhoA\/ROCK signaling regulates chondrogenesis in a context-dependent manner","volume":"281","author":"Woods","year":"2006","journal-title":"J Biol Chem"},{"key":"B13","article-title":"RhoA\/ROCK pathway: implication in osteoarthritis and therapeutics targets","volume":"11","author":"Deng","year":"2019","journal-title":"Am J Transl Res"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1142\/9789813228795_0008","article-title":"Modulation of osteoclast differentiation and function by rho GTPases","volume-title":"Rho GTPases: Molecular biology in health and disease","author":"Wang","year":"2018"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.03.033","article-title":"ROCK inhibitors enhance bone healing by promoting osteoclastic and ostetoblastic differentiation","volume":"526","author":"Nakata","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2017.02.005","article-title":"Functions of rho family of small GTPases and rho-associated coiled-coil kinases in bone cells during differentiation and mineralization","volume":"1861","author":"Strzelecka-Kiliszek","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nature02444","article-title":"Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone systems","volume":"428","author":"Koga","year":"2004","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aan0023","article-title":"Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling","volume":"10","author":"Uehara","year":"2017","journal-title":"Sci Signal"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4161\/sgtp.29846","article-title":"Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions","volume":"5","author":"Julian","year":"2014","journal-title":"Small GTPases"},{"key":"B22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/21541248.2016.1173770","article-title":"Made to measure-keeping rho kinase at a distance","volume":"7","author":"Truebestein","year":"2016","journal-title":"Small GTPases"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.06.018","article-title":"ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma","volume":"20","author":"Sanz-Moreno","year":"2011","journal-title":"Cancer Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-019-01153-w","article-title":"Targeting ROCK\/LIMK\/cofilin signaling pathway in cancer","volume":"42","author":"Lee","year":"2019","journal-title":"Arch Pharm Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.03.008","article-title":"ROCK inhibition in models of neurodegeneration and its potential for clinical translation","volume":"189","author":"Koch","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(04)82005-4","article-title":"The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease","volume":"82","author":"Monach","year":"2004","journal-title":"Adv Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"R224","DOI":"10.1186\/ar3211","article-title":"Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K\/BxN serum-tranfer arthritis model","volume":"12","author":"Garcia","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00774-014-0607-5","article-title":"Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis","volume":"73","author":"Orosa","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/art.42065","article-title":"Central role of semaphorin 3B in a serum-induced arthritis model and reduced levels in patients with rheumatoid arthritis","volume":"74","author":"Igea","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.11.010","article-title":"Osteoclastogenic capacity of peripheral blood mononuclear cells is not different between women with and without osteoporosis","volume":"95","author":"Koek","year":"2017","journal-title":"Bone"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0505789102","article-title":"The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption","volume":"102","author":"van der Eerden","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.3.1601","article-title":"Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis","volume":"167","author":"Wipke","year":"2001","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/ar1761","article-title":"A crucial role for macrophages in the pathology of K\/BxN serum-induced arthritis","volume":"35","author":"Solomon","year":"2005","journal-title":"Eur J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4110\/in.2019.19.e2","article-title":"Osteoclasts in the inflammatory arthritis: implications for pathologic osteolysis","volume":"19","author":"Jung","year":"2019","journal-title":"Immune Netw"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI26132","article-title":"M-CSF mediates TNF-induced inflammatory osteolysis","volume":"115","author":"Kitaura","year":"2005","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1155\/2013181849","article-title":"Immunological reaction in TNF-a-mediated osteoclast formation and bone resorption in vitro and in vivo","volume":"2013","author":"Kitaura","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01483","article-title":"How autoantibodies regulate osteoclast induced bone loss in rheumatoid arthritis","volume":"10","author":"Steffen","year":"2019","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2013.04.002","article-title":"Osteoclasts in RA: diverse origins and functions","volume":"80","author":"Le Goff","year":"2013","journal-title":"Joint Bone Spine"},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.1142\/9789813228795_0008","article-title":"Modulation of osteoclast differentiation and function by rho GTPases","volume-title":"Rho GTPases: Molecular biology in health and disease","author":"Wang","year":"2018"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2016.08.042","article-title":"Distinctive and selective route of PI3K\/PKC\u03b1-PKC\u03b4\/RhoA-Rac1 signaling in osteoclastic cell migration","volume":"437","author":"Kim","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2008.03.002","article-title":"Rho GTPases in osteoclasts: orchestrators of podosome arrangement","volume":"87","author":"Ory","year":"2008","journal-title":"Eur J Cell Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.16.11993","article-title":"Rho-a is critical for osteoclast podosome organization, motility, and bone resorption","volume":"275","author":"Chellaiah","year":"2000","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-015-0382-6","article-title":"Novel insights into the roles of rho kinase in cancer","volume":"64","author":"Wei","year":"2016","journal-title":"Arch Immunol Ther Exp"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070733","article-title":"RhoA as a key regulator of innate and adaptive immunity","volume":"8","author":"Bros","year":"2019","journal-title":"Cells"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.7150\/thno.30305","article-title":"Rho-associated coiled-coil kinase (ROCK) in molecular regulation of angiog\u00e9nesis","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/art.23986","article-title":"Antiinflammatory effect of rho kinase blockade via inhibition of NF-kappaB activation in rheumatoid arthritis","volume":"58","author":"He","year":"2008","journal-title":"Arthritis Rheumatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/art.25063","article-title":"Inhibition of NF-kappaB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis","volume":"62","author":"Okamoto","year":"2010","journal-title":"Arthritis Rheumatol"},{"key":"B48","article-title":"Rodent models of rheumatoid arthritis","volume":"55","author":"Brand","year":"2005","journal-title":"Comp Med"},{"key":"B49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-7643-7520-1_1","article-title":"Rat models of arthritis: Similarities, differences, advantages, and disadvantages in the identification of novel therapeutics","volume-title":"In vivo models of inflammation","author":"Schopf","year":"2006"},{"key":"B50","doi-asserted-by":"crossref","first-page":"120.23","DOI":"10.4049\/jimmunol.188.Supp.120.23","article-title":"The role of the rho-associated kinase ROCK in the differential regulation of CXCL8 and CCL2 production by caco-2 epithelial cells","volume":"188","author":"Perey","year":"2012","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/s1534-5807804900075-9","article-title":"Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment","volume":"6","author":"McBeath","year":"2004","journal-title":"Dev Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/scrt318","article-title":"Mechanically induced osteogenic lineage commitment of stem cells","volume":"4","author":"Chen","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2011.0293","article-title":"Bone morphogenetic protein-2-induced signaling and osteogenesis is regulated by cell shape, RhoA\/ROCK, and cytoskeletal tension","volume":"21","author":"Wang","year":"2012","journal-title":"Stem Cells Dev"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-009-0976-6","article-title":"Stimulation of ectopic bone formation in response to BMP-2 by rho kinase inhibitor: a pilot study","volume":"467","author":"Yoshikawa","year":"2009","journal-title":"Clin Orthop Relat Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cells5020017","article-title":"The regulation of cellular responses to mechanical cues by rho GTPases","volume":"5","author":"Hoon","year":"2016","journal-title":"Cells"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90677.2008","article-title":"Activation of AMP kinase and inhibition of rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression","volume":"296","author":"Kanazawa","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.180919","article-title":"Neogenin, a receptor for bone morphogenetic proteins","volume":"286","author":"Hagihara","year":"2011","journal-title":"J Biol Chem"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2005.12.002","article-title":"Essential requirement for rho family GTPase signaling in Pax3 induced mesenchymal-epithelial transition","volume":"18","author":"Wiggan","year":"2006","journal-title":"Cell Signal"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25100","article-title":"RhoA-mediated functions in C3H10T1\/2 osteoprogenitors are substrate topography dependent","volume":"231","author":"Ogino","year":"2016","journal-title":"J Cell Physiol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/0264-6021:3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davis","year":"2000","journal-title":"Biochem J"},{"key":"B61","article-title":"Pharmacological properties of y-27632, a specific inhibitor of rho-associated kinases","volume":"57","author":"Ishizaki","year":"2000","journal-title":"Mol Pharmacol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1471-4159.2002.00801","article-title":"Inhibition of rho-kinase-induced myristoylated alanine-rich c kinase substrate (MARCKS) phosphorylation in human neuronal cells by h-1152, a novel and specific rho-kinase inhibitor","volume":"81","author":"Ikenoya","year":"2002","journal-title":"J Neurochem"},{"key":"B63","doi-asserted-by":"publisher","first-page":"288ra76","DOI":"10.1126\/scitranslmed.aaa4616","article-title":"Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy","volume":"7","author":"Doody","year":"2015","journal-title":"Sci Transl Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau8217","article-title":"Treating murine inflammatory diseases with an anti-erythrocyte antibody","volume":"11","author":"Crow","year":"2019","journal-title":"Sci Transl Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205696","article-title":"Choline kinase inhibition in rheumatoid arthritis","volume":"74","author":"Guma","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/annrheumdis-2018-214827","article-title":"Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomized, double-blind, placebo-controlled phase 3 trial","volume":"78","author":"Takeuchi","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208052","article-title":"Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with rheumatoid artgritis on methotrexate to validate inhibitory effect on bone erosion (DRIVE)-a 12-month, multicentre, randomized, double-blind, placebo-controlled, phase II clinical trial","volume":"75","author":"Takeuchi","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULSR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.123729","article-title":"No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study","volume":"70","author":"D\u00d8hn","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.149377","article-title":"Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with low-field MRI","volume":"70","author":"Gandjbakhch","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001525","article-title":"Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy","volume":"7","author":"Sundin","year":"2021","journal-title":"RMD Open"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.858069\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:31:03Z","timestamp":1676367063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.858069\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":71,"alternative-id":["10.3389\/fimmu.2022.858069"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.858069","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"article-number":"858069"}}